The extortion deadline passed, and on Thursday, ShinyHunters made good on its threat.
One command and a scheduler replaced my entire subscription.
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...